Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q2 EPS of ($0.59), $0.54 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.9 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.